March 05, 2015 11:00 PM ET

Healthcare Providers and Services

Company Overview of Aurora Diagnostics, LLC

Company Overview

Aurora Diagnostics, LLC, a specialized laboratory company, provides unsurpassed diagnostic, prognostic, and therapeutic information and services to physicians, hospital systems, and researchers in the United States. It offers pathology services, such as dermatopathology, gastrointestinal and hepatic pathology, hematopathology, and genitourinary; and pathology services to women’s health care providerpathology. The company also provides molecular diagnostic services that focus on pharmacogenomics, oncology, women’s health, and infectious diseases; and hospital-based clinical and management solutions, such as anatomic and clinical, professional component, and technical component pathology servi...

11025 RCA Center Drive

Suite 300

Palm Beach Gardens, FL 33410

United States

Founded in 2006

1,102 Employees





Key Executives for Aurora Diagnostics, LLC

Chief Executive Officer and President
Age: 66
Chief Information Officer and Senior Vice President
Age: 46
Special Advisor and Manager
Age: 68
Executive Vice President of Sales & Marketing
Age: 44
Compensation as of Fiscal Year 2014.

Aurora Diagnostics, LLC Key Developments

Aurora Diagnostics Announces New Credit Facility

Aurora Diagnostics announced that it has entered into a new five-year credit facility with Cerberus Business Finance, LLC effective July 31, 2014. The new agreement includes a $165,000,000 term loan and a $30,000,000 revolving credit line, as well as a $25,000,000 delayed draw term loan facility. Approximately $145,600,000 of the proceeds under the new credit facility were used to pre-pay all amounts outstanding under Aurora’s existing secured credit facility term loan and revolver. The balance of the proceeds under the new credit facility, including the availability under the revolving line of credit, will be used for potential future acquisitions and for Aurora’s general working capital and operational needs.

Aurora Diagnostics Reports Financial Results for the First Quarter Ended March 31, 2014

Aurora Diagnostics, LLC reported financial results for the first quarter ended March 31, 2014. Net revenue in the first quarter was $57 million compared to $61 million for the first quarter of the prior year, a decrease of approximately $4 million or 6%. Average revenue per accession decreased to $115 for the first quarter of 2014 from $117 for the same period in 2013, representing a $1.3 million reduction in net revenue. The decrease in the revenue per accession compared to the first quarter of '13 was primarily caused by reductions in Medicare reimbursement rates, including changes to the fee schedule effective January 1, 2014, and sequestration, which became effective April 1, 2013. Adjusted EBITDA was $7.6 million for the quarter ended March 31, 2014, compared to $7.7 million for the first quarter of 2013.

Aurora Diagnostics, LLC, Q1 2014 Earnings Call, May 20, 2014

Aurora Diagnostics, LLC, Q1 2014 Earnings Call, May 20, 2014

Similar Private Companies By Industry

Company Name Region
CompuData, Inc. United States
RegionalCare Hospital Partners, Inc. United States
The Family Medical Group LLC United States
Huntington Artificial Kidney Center, Ltd. United States
Coventry Health Care of Virginia, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aurora Diagnostics, LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at